Artennua is an optimized version of Artemisia annua, a medicinal plant used for centuries in Chinese Medicine that is the only natural source of Artemisinin. Artemisinin is the molecule recommended by the WHO to treat malaria.
Artemisinin, its derivatives, and other secondary metabolites contained in the plant Artemisia annua, have the potential to treat a broad range of diseases and afflictions. However, Artemisia annua produces very low quantities of artemisinin and thus its global supply is limited.
As scientists and social entrepreneurs, we have used natural plant biopharming methods to improve some characteristics of the Artemisia annua plant meaning its therapeutic properties can now be exploited more extensively.
In the fight against COVID-19, which has generated thousands of infected and deceased, unceasing research and tests continue in order to find effective treatments against this aggressive virus. Around the world, different research institutions and companies have been working to discover new drugs and create new therapies. But of special utility, in order to minimize…
In our continuous R+D processes, Biotech Tricopharming Research, in collaboration with the National Centre for Food Technology and Safety (CNTA), has carried out an evaluation of the antioxidant therapeutic potential of Artennua®, our Artemisia annua plant optimized version, compared to other aromatic and medicinal plants (MAPs) with high antioxidant properties. The evaluation is part of…
Medicinal plant extracts may help into treatments of epidemic diseases like COVID-19 Nowadays it is everyone’s concern about what’s COVID-19 doing to society and what are the chances to fight against it. On March 13th, Nature Plants high-impact international journal came out with an interesting article showing how some well recognized botanical extracts may help…
